MHRA Drug Safety Update January 2022

MHRA Drug Safety Update January 2022

January 18, 2022

A new Medicines and Healthcare products Regulatory Agency (MHRA) Drug Safety Update (Vol 15 Issue 6 January 2022) has been published and includes articles on:

  • Brolucizumab (Beovu▼): risk of intraocular inflammation and retinal vascular occlusion increased with short dosing intervals
  • Paclitaxel formulations (conventional and nab-paclitaxel): caution required due to potential for medication error
  • COVID-19 vaccines and medicines: updates for January 2021
  • Letters and medicine recalls sent to healthcare professionals in December 2021

To see the latest MHRA Drug Safety Updates in full, visit the website

Posted in:

More Latest News >

HEE: Clinical Skills Training Survey

Health Education England (HEE) are seeking the views of frontline community pharmacists to support the development of further training modules that support pharmacists in the...

Drug Tariff Watch – June 2022

The Drug Tariff Preface published monthly lists additions, deletions and other changes to products listed in the Drug Tariff. Below...

Have you completed the DMS DoC?

Pharmacists and pharmacy technicians are reminded that they must complete the Discharge Medicines Service (DMS) Declaration of Competence (DoC) before...